Samples ready for testing - Photo credit: Rob Felt, Georgia Tech

We are proud and excited to announce that a study funded by the Laura Crandall Brown Foundation has resulted in a method to accurately and reliably detect ovarian cancer.  By utilizing mass spectrometry and a distinct computer algorithm, researchers at Georgia Tech were able to detect specific metabolite levels in the blood that indicated the presence of early-stage ovarian cancer.  The study results, titled "Highly accurate metabolomics detection of early-stage ovarian cancer," were published recently in the November 17 issue of the peer-reviewed journal Nature.  

Click here to read more about the study and here to view the journal publication.

More extensive testing of this method is needed across a larger group of women to ensure the high accuracy remains consistent, but LCBF is honored to have played a part in this important progress made in the early detection of ovarian cancer.  

Thank you to all of our generous donors and supporters who enable the Laura Crandall Brown Foundation to make strides in the areas of research, awareness, and support.  Every day we work hard to ensure your donations have the greatest impact possible!